The Breast is an international, multidisciplinary journal for researchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer prevention, diagnosis and treatment of all stages.
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers.
来源期刊：BreastDOI：10.1016/j.breast.2019.07.001
Homologous recombination deficiency in triple negative breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.02.007
Long non-coding RNA HOTAIR in circulatory exosomes is correlated with ErbB2/HER2 positivity in breast cancer.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.05.003
Targeting CDK4/6 pathways and beyond in breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2018.10.001
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
来源期刊：BreastDOI：10.1016/j.breast.2019.07.006
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.010
Cancer treatment effects on cognition and depression: The moderating role of physical activity.
来源期刊：BreastDOI：10.1016/j.breast.2019.01.004
Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.009
Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.011
Postmastectomy radiotherapy in T1-2 patients with one to three positive lymph nodes - Past, present and future.
来源期刊：BreastDOI：10.1016/j.breast.2019.09.008
Low eicosapentaenoic acid and gamma-linolenic acid levels in breast adipose tissue are associated with inflammatory breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.04.001
Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study.
来源期刊：BreastDOI：10.1016/j.breast.2019.01.003
Effects of pessimism, depression, fatigue, and pain on functional health-related quality of life in patients with resected non-advanced breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.01.012
Patient-reported health problems and healthcare use after treatment for early-stage breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.03.010
Consumer and clinician perspectives on personalising breast cancer prevention information.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.002
Peptide vaccines in early breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.02.003
Occupational exposures and male breast cancer: A nested case-control study in the Nordic countries.
来源期刊：BreastDOI：10.1016/j.breast.2019.09.004
Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.008
Results of PONDx, a prospective multicenter study of the Oncotype DX® breast cancer assay: Real-life utilization and decision impact in French clinical practice.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.015
Pathways to care for patients in Pakistan experiencing signs or symptoms of breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.04.005
Meta-analysis of long-term efficacy and safety of hypofractionated radiotherapy in the treatment of early breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.08.001
The changes of quality of life and their correlations with psychosocial factors following surgery among women with breast cancer from the post-surgery to post-treatment survivorship.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.011
Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study.
来源期刊：BreastDOI：10.1016/j.breast.2019.09.010
Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?
来源期刊：BreastDOI：10.1016/j.breast.2019.05.009
A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.010
Breast cancer medical malpractice litigation in New York: The past 10\u202fyears.
来源期刊：BreastDOI：10.1016/j.breast.2019.03.009
Towards mm-wave spectroscopy for dielectric characterization of breast surgical margins.
来源期刊：BreastDOI：10.1016/j.breast.2019.02.008
Lymph node infiltration, parallel metastasis and treatment success in breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.07.008
Prepectoral direct-to-implant breast reconstruction with complete ADM or synthetic mesh coverage - 36-Months follow-up in 200 reconstructed breasts.
来源期刊：BreastDOI：10.1016/j.breast.2019.08.002
Endoscopic-assisted surgery in the management of breast cancer: 20 years review of trend, techniques and outcomes.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.05.013
Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.04.003
Primary predictors of survival outcomes for HER2-positive advanced breast cancer patients initiating ado-trastuzumab emtansine.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.05.011
Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.007
Self-reported work ability in breast cancer survivors; a prospective cohort study in the Netherlands.
来源期刊：BreastDOI：10.1016/j.breast.2019.08.004
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trials.
来源期刊：BreastDOI：10.1016/j.breast.2019.04.004
Is trastuzumab as a single agent obsolete in early breast cancer? No.
来源期刊：BreastDOI：10.1016/j.breast.2018.09.002
Changes in employment status up to 5 years after breast cancer diagnosis: A prospective cohort study.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.07.007
De-escalation of complexity in oncoplastic breast surgery: Case series from a specialized breast center.
来源期刊：BreastDOI：10.1016/j.breast.2019.04.002
Safety of menopausal hormone therapy in breast cancer survivors older than fifty at diagnosis: A systematic review and meta-analysis.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.06.002
Is tumor bed boost necessary in patients who achieved ypCR following neoadjuvant chemotherapy and breast conserving therapy? (KROG 12-05 and 16-16).
来源期刊：BreastDOI：10.1016/j.breast.2019.02.010
Patient-reported fatigue in breast cancer patients receiving radiation therapy.
来源期刊：BreastDOI：10.1016/j.breast.2019.06.004
Adjuvant radiation therapy in small ductal carcinoma in situ.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.004
Breast cancer follow-up after a primary diagnosis: A confused picture.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.05.010
Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.005
